Oramed Pharmaceuticals Inc. 13D and 13G filings for Scilex Holding Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 4:10 pm Sale | 2025-12-31 | 13G | SCILEX HLDG CO COM SCLX | ORAMED PHARMACEUTICALS INC. ORMP | 437,510 4.900% | -395,963 (-47.51%) | Filing |
| 2025-11-14 4:30 pm Purchase | 2025-09-30 | 13G | SCILEX HLDG CO COM SCLX | ORAMED PHARMACEUTICALS INC. ORMP | 833,473 9.900% | 69,196 (+9.05%) | Filing |
| 2025-08-14 6:56 pm Purchase | 2025-06-30 | 13G | SCILEX HLDG CO COM SCLX | ORAMED PHARMACEUTICALS INC. ORMP | 764,277 9.900% | 31,560 (+4.31%) | Filing |